Murine interferon-α1 gene-transduced ESb tumor cells are rejected by host-mediated mechanisms despite resistance of the parental tumor to interferon-α/α therapy

Cancer Gene Therapy

Volumn 6, Issue 3, 1999, Pages 246-253

  Rozera, Carmela ^a   Mecchia, Monica ^a   Gresser, Ion ^b   Bandu, Marie Therese ^b   Proietti, Enrico ^a   Venditti, Massimo ^a   Sestili, Paola ^a   Santini, Stefano Maria ^a   Fais, Stefano ^a   Belardelli, Filippo ^a   Ferrantini, Maria ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b CNRS   (France)

Author keywords

Antitumor immune response; Gene transfer; Interferon

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON;

ANIMAL; ARTICLE; CELL CULTURE; DBA MOUSE; EXPERIMENTAL NEOPLASM; GENE TRANSFER; GENETICS; IMMUNOLOGY; MALE; MOUSE; MULTIDRUG RESISTANCE; RETROVIRUS; TIME;

ANIMALS; DRUG RESISTANCE, MULTIPLE; GENE TRANSFER TECHNIQUES; INTERFERON-ALPHA; INTERFERON-BETA; MALE; MICE; MICE, INBRED DBA; NEOPLASMS, EXPERIMENTAL; RETROVIRIDAE; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0033125156     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700051     Document Type: Article

References (30)

1. Hussein AM. The potential application of gene transfer in the treatment of patients with cancer: a concise review. Cancer Invest. 1996;14:343-352.
2. 1-interferon gene transfer into metastatic Friend leukemia cells abrogated tumorigenicity in immunocompetent mice: antitumor therapy by means of interferon-producing cells. Cancer Res. 1993;53:1107-1112.
3. + T cell-mediated tumor rejection and development of antitumor immunity: comparative studies with IFN-γ-producing TS/A cells. J Immunol. 1994; 153:4604-4615.
4. Kaido T, Bandu MT, Maury C, et al. IFN-α gene transfection completely abolishes the tumorigenicity of murine B16 melanoma cells in allogeneic DBA/2 mice and decreases their tumorigenicity in syngeneic C57BL/6 mice. Int J Cancer. 1995;60:1-9.
5. 1-transfected Friend leukemia cells. Am J Pathol. 1995;147:445-460.
6. Affabris E, Jemma C, Rossi GB. Isolation of interferon-resistant variants of Friend erythroleukemia cells: effects of interferon and ouabain. Virology. 1982;120:441-452.
7. Belardelli F, Gresser I, Maury C, Maunoury MT. Antitumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. I. Int J Cancer. 1982;30:813-820.
8. Belardelli F, Gresser I, Maury C, et al. Antitumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells: inhibition of growth and necrosis of tumors implanted subcutaneously. Int J Cancer. 1983;31:649-653.
9. Gresser I, Maury C, Woodrow D, et al. Interferon treatment markedly inhibits the development of tumor metastases in the liver and spleen and increases survival time of mice after intravenous inoculation of Friend erythroleukemia cells. Int J Cancer. 1988;41:135-142.
10. Schirrmacher V, Shantz G, Clauer K, et al. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice: tumor invasiveness in vitro and metastasis formation in vivo. Int J Cancer. 1979;23:233-244.
11. Puddu P, Locardi C, Sestili P, et al. Human immunodeficiency virus (HIV)-infected tumor xenografts as an in vivo model for antiviral therapy: role of α/β interferon in restriction of tumor growth in nude mice injected with HIV-infected U937 tumor cells. J Virol. 1991;65:2245-2253.
12. Markowitz D, Goff S, Bank A. A safe packaging line for gene transfer: separating viral genes on two different plasmids. J Virol. 1988;62:1120-1124.
13. Markowitz D, Goff S, Bank A. Construction and use of a safe and efficient amphotropic packaging cell line. Virology. 1988;167:400-406.
14. Belardelli F, Gessani S, Proietti E, et al. Studies on the expression of spontaneous and induced interferons in mouse peritoneal macrophages by means of monoclonal antibodies to mouse interferons. J Gen Virol. 1987;68: 2203-2212.
15. Miller AD, Rosman GJ. Improved retroviral vectors for gene transfer and expression. BioTechniques. 1989;7:980-984.
16. Shaw GD, Boll W, Taira H, et al. Structure and expression of cloned murine IFN-α genes. Nucleic Acid Res. 1983;11: 555-573.
17. + T cells and IFN-α/β. Int J Cancer. 1994;57:538-543.
18. Gresser I. The effect of interferon on experimental tumor metastases. In: Schirrmacher V, Schwartz-Albeiz R, eds. Cancer Metastasis. Berlin: Springer; 1989:171-180.
19. Gresser I. Antitumor effects of interferon. Acta Oncol. 1989;28:347-353.
20. Rossi D, Fumagalli S, Volpi L, Larizza L. Differential induction of the two early genes c-jun and c-fos in weakly and strongly metastatic murine lymphoma cell lines. Int J Cancer. 1994;57:86-89.
21. Kowitz A, Kadmon G, Verschueren H, et al. Expression of L1 cell adhesion molecule is associated with lymphoma growth and metastasis. Clin Exp Metastasis. 1993;11:419-429.
22. Gabriele L, Proietti E, Greco G, et al. Isolation and characterization of a metastatic Eb-like tumor variant highly responsive to interleukin (IL)-2 and to combination cytokine therapy with IL-2/IL-1β and IL-1β/interferon-α/β. Invasion Metastasis. 1993;13:147-162.
23. Schirrmacher V, Bosslet K, Shantz G, et al. Tumour metastases and cell-mediated immunity in a model system in DBA/2 mice: antigenic differences between the parental tumor line and its metastasizing variant. Int J Cancer. 1979;23:245-252.
24. + T lymphocytes are required for the synergistic action of interferon-α/β and adoptively transferred immune cells in the inhibition of visceral ESb metastases. Cancer Res. 1995;55:6133-6139.
25. Heicappell R, Schirrmacher V, von Hoegen P, et al. Prevention of metastatic spread by postoperative immuno-therapy with virally modified autologous tumor cells. Int J Cancer. 1986;37:569-577.
26. Von Hoegen P, Heicappell R, Griesbach A, et al. Prevention of metastatic spread by postoperative immunotherapy with virally modified autologous tumor cells: postoperative activation of tumor-specific CTLP from mice with metastases requires stimulation with the specific antigen plus additional signals. Invasion Metastasis. 1989;9:117-133.
27. Von Hoegen P, Zawatzky R, Schirrmacher V. Modification of tumor cells by a low dose of Newcastle disease virus: potentiation of tumor-specific cytolytic T cell activity via induction of interferon-α/β. Cell Immunol. 1990;126: 80-90.
28. Schirrmacher V, Leidig S, Griesbach A. In situ activation of syngeneic tumor specific cytotoxic T-lymphocytes: intra-pinna immunization followed by restimulation in the peritoneal cavity. Cancer Immunol Immunother. 1991;33:299-306.
29. Tough DF, Borrow P, Sprent J. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science. 1996;272:1947-1950.
30. Qin Z, Kruger-Krasagakes S, Kunzendorf U, et al. Expression of tumor necrosis factor by different tumor cell lines results in either tumor suppression or augmented metastasis. J Exp Med. 1993;178:355-360.